PAVmed Inc (PAVM)
2.07
-0.17
(-7.59%)
USD |
NASDAQ |
May 03, 16:00
2.10
+0.03
(+1.45%)
After-Hours: 20:00
PAVmed Research and Development Expense (Quarterly): 3.595M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.595M |
September 30, 2023 | 3.161M |
June 30, 2023 | 3.469M |
March 31, 2023 | 4.439M |
December 31, 2022 | 6.674M |
September 30, 2022 | 6.202M |
June 30, 2022 | 6.74M |
March 31, 2022 | 5.932M |
December 31, 2021 | 6.969M |
September 30, 2021 | 5.305M |
June 30, 2021 | 4.258M |
March 31, 2021 | 3.315M |
December 31, 2020 | 3.642M |
September 30, 2020 | 2.619M |
June 30, 2020 | 2.133M |
March 31, 2020 | 2.628M |
December 31, 2019 | 2.254M |
September 30, 2019 | 1.52M |
Date | Value |
---|---|
June 30, 2019 | 1.405M |
March 31, 2019 | 1.451M |
December 31, 2018 | 1.368M |
September 30, 2018 | 1.173M |
June 30, 2018 | 1.149M |
March 31, 2018 | 0.5632M |
December 31, 2017 | 0.5582M |
September 30, 2017 | 0.7049M |
June 30, 2017 | 0.7017M |
March 31, 2017 | 0.6567M |
December 31, 2016 | 0.607M |
September 30, 2016 | 0.5785M |
June 30, 2016 | 0.355M |
March 31, 2016 | 0.1791M |
December 31, 2015 | 0.1413M |
September 30, 2015 | 0.2645M |
June 30, 2015 | 0.0674M |
March 31, 2015 | 0.016M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.405M
Minimum
Jun 2019
6.969M
Maximum
Dec 2021
4.014M
Average
3.595M
Median
Dec 2023
Research and Development Expense (Quarterly) Benchmarks
Cutera Inc | 4.564M |
Dynatronics Corp | -- |
Stereotaxis Inc | 2.212M |
Electromed Inc | 0.107M |
Myomo Inc | 0.878M |